Moreover, it is unclear whether the apparently low detection rate of MET-GCNG/GA in MM using DNA/RNA-sequencing techniques could in fact reflect intratumor heterogeneity resulting in the presence of this MET alteration only in minor, difficult-to-detect MM cell populations within the tumor tissue. This evidence concerns the gene MET and Miyoshi myopathy.